SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AtheroGenics, Inc.{AGIX}-nasdaq
An SI Board Since September 2000
Posts SubjectMarks Bans Symbol
332 21 0 AGIX
Emcee:  Secret_Agent_Man Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
307<<Dr. Fleming is President and Chief Executive Officer of Kinexum LLC, a pmlrb2113-10/21/2007
306<i>AtheroGenics, Inc. (NASDAQ: AGIX),... today announced the resignation oClarksterh-10/19/2007
305AtheroGenics Announces Change in Chief Medical Officer G. Alexander Fleming, M.sim1-10/18/2007
304Another link courtesy of Trumangov. A summary of all the oral diabetes meds andClarksterh-9/11/2007
303Lots of new results in the presentation just made. But probably the most signifClarksterh-9/7/2007
302Courtesy of trumangovt on yahoo - a link to the presentation just made by AtheroClarksterh-9/7/2007
301Thanks; searching with "AGI-1067" as the keyword gets that hit now. Dtuck-9/6/2007
300<i>The protocol for the ANDES trial isn't on clincialtrials.gov or cenClarksterh-9/6/2007
299Ditto thanks. You saved me some pain by making me look hard at the surface of tkeokalani'nui-9/6/2007
298>>a good bet that the placebo arm with baseline HbA1C>8 started a lot mtuck-9/6/2007
297Some interesting speculation (I was looking through the data vs other diabetes tClarksterh-9/5/2007
296>>AtheroGenics Announces New ARISE Diabetes Data on AGI-1067 Presented at tuck-9/5/2007
295A Failed Heart Drug Becomes an Experimental Diabetes Drug Posted by Jacob GoldsDoc Bones-8/31/2007
294AtheroGenics Announces First Patients Enrolled in ANDES Phase III Diabetes Cliniidos-8/23/2007
293More Bad About Avandia: firstwordplus.commlrb2113-7/19/2007
292Tax Strategy, fwiw: After my total luck (I know nothing about bios) with RNAI (Smlrb2113-7/10/2007
291I'm not surprised from what I've read that the MI risk from Avandia was mlrb2113-7/8/2007
290I've been reading a good (I think) paper on DILI that one of the apparent domlrb2113-7/8/2007
289An interesting thing about the interim results for Avandia vs other diabetes druClarksterh-7/6/2007
288Dr. Bob - I knew of the top line results, but had not seen the paper. Tx.Clarksterh-7/5/2007
287Rereading the questions that I wrote after the 1067 trial results came in and AtClarksterh-7/5/2007
286Clark: Have you seen this? content.nejm.orgmlrb2113-7/4/2007
285<i>are there refined tests that can detect small changes in liver functionClarksterh-7/2/2007
284What I mean is are there refined tests that can detect small changes in liver fumlrb2113-7/1/2007
283<<Also note that even if the lower doses of 1067 do reduce liver tox it ismlrb2113-7/1/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News